| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |